New York, NY (PRWEB) March 04, 2014
Kantar Health, a leading global healthcare consulting firm, today announced that Global CEO Lynnette Cooke and Global Compliance and Quality Director Jessica Santos, Ph.D., will present at the Pharmaceutical Marketing Research Group (PMRG) Annual National Conference March 10-11 in Orlando.
Ms. Cooke will moderate “Realizing Your Role as a Strategic Leader,” with panelists Scott Snyder, Ph.D., President and Chief Strategy Officer of Mobiquity, and Betty Adamou, CEO and Founder of Research Through Gaming. In this session, which will start at 3:30 pm on Monday, March 10, panelists and attendees will discuss such issues as what it means to be a strategic leader, advice for becoming a strategic leader and predictions for the healthcare marketing research industry.
In the second presentation, Dr. Santos and David Lee, Associate Director, Operations & Compliance with Merck, will present “A Perspective on Reducing Compliance Risk While Making Business Thrive” at 3:30 pm on Tuesday, March 11. Their session will cover how pharmaceutical manufacturers can work with internal stakeholders and satisfy external payers while their businesses thrive; agency audiences will learn to understand the demand from manufacturers and essential compliance elements for daily practice that do not compromise quality, speedy delivery and insight.
Kantar Health is a sponsor of the PMRG 2014 Annual National Conference. More information on this event can be found at http://www.pmrg.org/EventsWebinars/2014PMRGANC/tabid/872/Default.aspx.
About Kantar Health
Kantar Health is a leading global healthcare consulting firm and trusted advisor to many pharmaceutical, biotech, and medical device and diagnostic companies worldwide. It combines evidence-based research capabilities with deep scientific, therapeutic and clinical knowledge, commercial development know-how, and brand and marketing expertise to help clients evaluate opportunities, launch products and maintain brand and market leadership.
Kantar Health deeply understands the influence of patients, payers and physicians, especially as they relate to the performance and payment of medicines and the delivery of healthcare services. Its 700+ healthcare industry specialists work across the product lifecycle, from preclinical development to launch, acting as catalysts to successful decision-making in life sciences and helping clients prioritize their product development and portfolio activities, differentiate their brands and drive product success post-launch. For more information, please visit http://www.kantarhealth.com.